INNOVATIVE RESEARCH
The institute provides a world-class interdisciplinary training environment for the preparation of technically skilled students who are capable of filling the diverse workforce needs in biomedical sciences. With key assets including centers for the study of inflammation, immunity and infection, microbial pathogenesis, oncology, molecular and cellular medicine, and diagnostics and therapeutics, the institute delivers both academic and research value to the field.
We've launched a new bachelor's degree program. The program prepares students for employment in the biomedical industry or advanced degrees in science, business or law. Learn More
Breakthroughs in Georgia: Enterprising Biomedicine
In a very short time, Georgia State University has built an impressive research enterprise. It’s the Institute for Biomedical Sciences, and its scientists are unlocking new insights and answers to an array of diseases and ailments. Tens of millions of dollars in research grants flow into the institute each year, and the university is planning even more expansion.
More
Top Stories
Dr. Timothy Denning Awarded 2020 Distinguished Alumnus Award from University of Texas Medical Branch’s Graduate School of Biomedical Sciences
Dr. Timothy Denning, associate director of the Institute for Biomedical Sciences at Georgia State University, has been awarded the 2020 Distinguished Alumnus Award from the University of Texas Medical Branch’s Graduate School of Biomedical Sciences (GSBS). read more ❯
Biomedical Sciences Researchers Find Certain Foods Common in Diets of U.S. Adults with Inflammatory Bowel Disease
Foods, such as French fries, cheese, cookies, soda, and sports and energy drinks, are commonly found in the diets of United States adults with inflammatory bowel disease, according to a new study by researchers in the Institute for Biomedical Sciences at Georgia State University.read more ❯
Georgia State Researchers Survey Antibodies to SARS-CoV-2 in Blood Samples of Local Residents
Georgia State researchers have measured antibodies to SARS-CoV-2, the virus that causes the disease COVID-19, in self-collected blood samples from Metro Atlanta residents. read more ❯